- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01387945
Pilot Study of Home Blood Pressure Control Program (eBP Control) (eBPcontrol)
March 31, 2016 updated by: Charles B. Eaton, Memorial Hospital of Rhode Island
This intervention study will evaluate the feasibility,acceptability and effectiveness of an e-health enabled model of care by randomly assigning a trained patient navigator and/or a blood pressure (BP) self-management web portal to patients with uncontrolled hypertension after a run in period with a home BP monitor (HBPM) and comparing the results on blood pressure control.
We anticipate that patients receiving the combination of a patient navigator(PN)with a self-management web portal and home BP monitor will have better BP control than when the only received a home BP monitor.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study will demonstrate and evaluate the feasibility and acceptability of an e-health enabled model of care for improved hypertension and elevated blood pressure control using a home blood pressure monitor (HBPM), a blood pressure (BP) self-management web portal, and a trained patient navigator.
During the first or the control period, all of the participants will have access to the only the HBPM.
The control period will be compared to the final or the intervention period when the participants will gain access to a trained patient navigator and the web portal.
This comparison will assist in estimating the effect sizes of the HBPM plus PN plus self-management web portal to HBPM alone for each of the outcomes: patient activation, self-management activities, medication adherence, reduced clinical inertia, and improved BP control.
The second of the randomization periods will allocate a patient navigator to half of the participants, while the other half will gain access to only the web portal.
We will compare the effectiveness of the PN plus webportal plus HBPM to webportal plus HBPM during this second period.
An evaluation of the intervention process will delineate the barriers and facilitators by the providers, participants, and patient navigators.
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rhode Island
-
Pawtucket, Rhode Island, United States, 02860
- Memorial Hospital of Rhode Island
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Diagnosed w/ hypertension or elevated blood pressure, uncontrolled blood pressure at the baseline research visit according to the following risk levels:
- Average risk,
- SBP >140 mmHg or DBP > 90 mmHg;
- Vascular disease (cerebrovascular disease, coronary heart disease, diabetes mellitus, peripheral vascular disease, renal insufficiency)
- SBP >130 mmHg or DBP >80 mmHg;
- Left ventricular dysfunction,
- SBP 120 mmHg or DBP >80 mmHg;
- can read and understand English; must have access to internet
Exclusion Criteria:
- Unable to comply with protocol;
- pregnancy;
- secondary hypertension (e.g. renovascular);
- participation in other hypertension clinical trials;
- hospitalized in the past six months for diabetes, renal failure, or heart failure;
- severe renal insufficiency (estimated glomerular filtration rate < 30 mL/min);
- patient already routinely using a home blood pressure monitoring device or patient not able to use HBPM device due to disability;
- arm circumference larger than 17 inches determined during telephone screener,
- arm circumference smaller than 9 inches measured at baseline research visit.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: HBPM only
|
|
|
Experimental: HBPM+website+patient navigator
|
In addition to home blood pressure monitor, patient receives access to BP web portal and trained patient navigator.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent of patients at BP goal
Time Frame: Nine months
|
Percentage of patients at systolic and/or diastolic blood pressure at goal at the fourth research visit (end of the study)
|
Nine months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health status
Time Frame: Nine Months
|
SF-12 questionnaire, patient activation
|
Nine Months
|
|
Use of intervention tools
Time Frame: Nine months
|
home blood pressure monitor-amount of time at goal; number of times patient utilized the website
|
Nine months
|
|
Costs
Time Frame: Nine months
|
Nine months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Charles B Eaton, MD, Memorial Hospital of Rhode Island
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
May 1, 2012
Study Completion (Actual)
September 1, 2012
Study Registration Dates
First Submitted
July 1, 2011
First Submitted That Met QC Criteria
July 5, 2011
First Posted (Estimate)
July 6, 2011
Study Record Updates
Last Update Posted (Estimate)
April 4, 2016
Last Update Submitted That Met QC Criteria
March 31, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCT 01242319
- 1R21HS018238-01 (U.S. AHRQ Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on HBPM+website+patient navigator
-
University of California, San FranciscoNational Institute on Aging (NIA); University of Minnesota; University of California... and other collaboratorsRecruiting
-
University of Illinois at ChicagoTerminatedHead and Neck CancerUnited States
-
Boston Medical CenterActive, not recruiting
-
Baystate Medical CenterCompleted
-
Medical University of South CarolinaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompleted
-
McGill University Health Centre/Research Institute...The Hospital for Sick Children; Canadian Institutes of Health Research (CIHR); Unity Health TorontoRecruitingPatient NavigationCanada
-
Case Comprehensive Cancer CenterCompletedPositive FIT or Stool DNA Testing Follow upUnited States
-
Memorial Sloan Kettering Cancer CenterNYU Langone Health; Ralph Lauren Center for Cancer Care and Prevention; Sophie... and other collaboratorsCompleted
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); University of Ottawa; Ontario... and other collaboratorsCompletedHealth Care Inequity, Patient NavigationCanada
-
University of AlbertaRecruitingChronic Diseases in AdolescenceCanada